Barely Significant
← all excerpts

Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy.

Br J Cancer · 1993 · PMC1968230 · PMID 7678979

Europe PMCDOI
2
hedged sentences
0.0050
closest p · 0.1× alpha
0.0050
boldest claim

The sentences

highly significantP <0.005actually significant
The results for the first cycle are given in Table IV, and it can be seen that the differences beween pretreatment and peak SI were highly significant (P <0.005 for each of the IL-2 con- centrations, Wilcoxon test).

also in 132,142 other papers

borderline significanceno p-value reported
The respective medians were 24% for all patients, 30% for patients achieving a CR/PR, and 20% for patients with PD. This difference between responders and non-responders reached statistical borderline significance (Table III).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.